Published in the Journal of Clinical Oncology, a review paper authored by a multidisciplinary group of international experts in DNA Damage Response (DDR) and PARP inhibition
Oncology Publication
Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy
Dr Judith Balmaña
Dr Rebecca Dent
Prof. Simon Boulton
Prof. Sibylle Loibl
Prof. Eric Pujade-Lauraine
Prof. Charlie Gourley
Dr Violeta Serra
Prof. Jonathan A. Ledermann
Publication Date
Sep 2021
Dr Judith Balmaña has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca.
Dr Rebecca Dent has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Eisai, Genentech, Lilly, Merck, Novartis, Pfizer and Roche.
Prof. Simon Boulton has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Artios Pharma Ltd.
Prof. Sibylle Loibl has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Amgen, Novartis, Pfizer and Roche.
Prof. Eric Pujade-Lauraine has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Clovis, Pfizer, Roche and Tesaro.
Prof. Charlie Gourley has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Apera, Clovis, MSD, Nucana, Novartis, Roche, Sierra Oncology and Tesaro.
Dr Violeta Serra has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca and Tesaro.
Prof. Jonathan A. Ledermann has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Clovis, Cristal Therapeutics, Pfizer, Roche and Seattle Genetics.
Programme summary
-
Duration
10 MIN
-
Downloadable resources
Yes
-
DOWNLOAD THE SLIDES
-
Language(s)
Other programmes of interest
Podcast
Episode
of
Oncology Rare diseases
Neuroendocrine tumours (NETs) shared decision-making: Exploring the patient journey and individualising treatments
Experts
Dr Mohid S Khan, Sally JenkinsEndorsed by
-
19 MIN
-
Jul 2024
Conference update
-
Downloadable
Resources -
03 MIN
-
Jul 2024
Podcast
Hemostasis and bleeding disorders Oncology
Cancer and Thrombosis
A podcast discussion on treating thrombosis in patients with cancer
Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis-
Downloadable
Resources -
14 MIN
-
Sep 2023
Oncology
Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer
An interactive patient case video series from breast cancer specialists
Experts
Dr Elisa Agostinetto, Prof. Valentina GuarneriEndorsed by
-
15 MIN
-
Sep 2023
Publication
Oncology Patient Support
Surveillance and Diagnosis of HCC in Asia: Poster Presentation at ILCA 2023
Data from an Asia-Pacific patient and HCP survey
Experts
Prof. Chee-Kiat Tan-
Downloadable
Resources -
5 MIN
-
Sep 2023
Video
Oncology
Long-term Response in Advanced Colorectal Cancer
A video update from Prof. Gerald Prager
Experts
Assoc. Prof. Gerald Prager-
Downloadable
Resources -
4 MIN
-
Sep 2023
